Longitudinal Assessment of Neurocognitive Function and Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) Undergoing Treatment
Sponsor study identifier
observational
104
1 country
1
Study Start
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2009
Actual (reported)Study Completion
March 2009
Actual (reported)Primary Objectives:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2009
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
April 11, 2007
Actual (reported)April 12, 2007
Actual (reported)March 2009
Actual (reported)March 2009
Actual (reported)Effect of cancer therapy on AML or MDS patients (longitudinal assessment neuropsychiatric (NP), neurocognitive (NC) symptoms, quality of life (QOL))
Interval testing will be approximately at 1 month, 3 months, and 6 months.
Effects of therapy on the ability to think, quality of life, the ability to perform everyday tasks, and how often side effects occur.
6 Years
AML and MDS Patients
Questionnaires taking about 30 minutes to complete.
Neurocognitive testing lasting 30 minutes. Patients will be asked to complete certain tasks that require the use of their hands, eyes, and ears.
Patients diagnosed with acute myelogenous leukemia or myelodysplastic syndrome.
U.T.M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
Christina A. Meyers, PhD
M.D. Anderson Cancer Center
104 participants (actual enrollment reported by the registry).
First Submitted
April 11, 2007
First Posted
April 12, 2007
Study Start
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
March 2009
Actual (reported)Study Completion
March 2009
Actual (reported)Last Updated
August 1, 2012
Record last verified: 2012-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: